Prevalence and distribution of peripheral musculoskeletal manifestations in spondyloarthritis including psoriatic arthritis: results of the worldwide, cross-sectional ASAS-PerSpA study (2021)
https://pubmed.ncbi.nlm.nih.gov/33462197

Risk of cancer in patients with ankylosing spondylitis: a nationwide cohort study in Taiwan. (2021)
https://pubmed.ncbi.nlm.nih.gov/33464145

Identification of clinical phenotypes of peripheral involvement in patients with spondyloarthritis, including psoriatic arthritis: a cluster analysis in the worldwide ASAS-PerSpA study (2021)
https://pubmed.ncbi.nlm.nih.gov/34750246

Efficacy and safety of brodalumab, an anti-IL17RA monoclonal antibody, in patients with axial spondyloarthritis: 16-week results from a randomised, placebo-controlled, phase 3 trial (2021)
https://pubmed.ncbi.nlm.nih.gov/33827787

Taiwan Rheumatology Association consensus recommendations for the management of axial spondyloarthritis. (2019)
https://pubmed.ncbi.nlm.nih.gov/31777200

Clinical Characteristics of Patients with Spondyloarthritis in Japan in Comparison with Other Regions of the World (2019)
https://pubmed.ncbi.nlm.nih.gov/30770497

Prevalence of comorbidities and evaluation of their screening in spondyloarthritis: results of the international cross-sectional ASAS-COMOSPA study. (2016)
https://pubmed.ncbi.nlm.nih.gov/26489703